Trials / Completed
CompletedNCT02261376
Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is an open label, non-randomised, single-dose, parallel-group study in 48 healthy subjects enrolled in 4 cohorts - Caucasian men, aged 18-55 years, Caucasian men, aged 65 years or older, Japanese men, aged 18-55 years, Caucasian women, aged 18-55 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-1971a | DS-1971a is supplied as a powder or crystals and will be given as an oral suspension with Bitrex® (taste masking agent). Each subject will receive a single oral dose of 200 mg DS 1971a . |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2014-10-10
- Last updated
- 2018-12-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02261376. Inclusion in this directory is not an endorsement.